Related references
Note: Only part of the references are listed.Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19
Peng Zhang et al.
CIRCULATION RESEARCH (2020)
Clinical characteristics of coronavirus disease 2019 (COVID-19) patients with hypertension on renin-angiotensin system inhibitors
Xian Zhou et al.
CLINICAL AND EXPERIMENTAL HYPERTENSION (2020)
Association of hypertension with the severity and fatality of SARS-CoV-2 infection: A meta-analysis
Jingqi Zhang et al.
EPIDEMIOLOGY AND INFECTION (2020)
Potential differential effects of renin-angiotensin system inhibitors on SARS-CoV-2 infection and lung injury in COVID-19
Masato Furuhashi et al.
HYPERTENSION RESEARCH (2020)
COVID-19: Social distancing, ACE 2 receptors, protease inhibitors and beyond?
George Thomson
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2020)
The SARS-CoV-2 outbreak: What we know
Di Wu et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)
Managing hypertension during the COVID-19 pandemic
Sunil K. Nadar et al.
JOURNAL OF HUMAN HYPERTENSION (2020)
ACE2 receptor polymorphism: Susceptibility to SARS-CoV-2, hypertension, multi-organ failure, and COVID-19 disease outcome
Christian A. Devaux et al.
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2020)
Covid-19: risk factors for severe disease and death
Rachel E. Jordan et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?
Lei Fang et al.
LANCET RESPIRATORY MEDICINE (2020)
COVID-19, hypertension and cardiovascular diseases: Should we change the therapy?
Marijana Tadic et al.
PHARMACOLOGICAL RESEARCH (2020)
Comparison of confirmed COVID-19 with SARS and MERS cases - Clinical characteristics, laboratory findings, radiographic signs and outcomes: A systematic review and meta-analysis
Ali Pormohammad et al.
REVIEWS IN MEDICAL VIROLOGY (2020)
Share Paper
